The unique way we diagnose and treat prostate cancer at Precision Prostate Cancer Care means that our results are unique as well.
A More Accurate Diagnosis Leads to Better Prostate Cancer Treatment
3D prostate cancer biopsy helps provide a much more accurate diagnosis for patients than traditional biopsy, which misses up to a third of all prostate cancers. The in-depth level of detail provided by a 3D prostate cancer biopsy, which uses up to 100 tissue samples vs. the standard 12, allows our physicians to make the most informed recommendations possible.
About 40 percent of patients who receive a 3D prostate cancer biopsy will quality for targeted focal cryotherapy prostate cancer treatment, which targets only the cancer cells in the prostate. We recommend active surveillance to about 30 percent of patients and either a prostatectomy or radiation therapy to the remainder. Our team has treated thousands of men with surgery, including robotic assisted and open prostatectomies, or radiation.
Patients who are candidates for targeted focal cryotherapy prostate cancer treatment have much lower complication rates than patients who have surgery or radiation. Because targeted focal cryotherapy prostate cancer treatment is an outpatient procedure, it has virtually no infection rate and no risk of transfusion. Plus, recovery time and post-procedure pain are much less than with other types of treatment.
While long-term results for targeted focal cryotherapy prostate cancer treatment are not yet available because the technique has only been available since 2006, so far our results have been phenomenal. After six years, our failure rate in properly selected patients is less than 10 percent. The majority of our patients experience minimal side effects and are maintaining potency and urinary continence.
And our patient satisfaction rates have been very positive as evidenced by these testimonials from past patients.
Real-Life Patient Examples
Here are the findings from several case studies we have overseen.
Through a traditional biopsy, Patient A was presented to our clinic with low-grade cancer on the right side. After 3D Staging Biopsy, we were able to determine the exact location of this individual’s cancer. We also established that the remainder of his prostate (depicted in red) was cancer free. This patient chose to undergo Targeted Focal Therapy.
Due to a continually rising PSA, Patient B had undergone 5 traditional biopsies, all of which failed to identify any cancer. Interested in obtaining a more complete diagnosis, he came to us for a second opinion, and subsequently underwent a 3D Staging Biopsy. The results indicated several areas of high-grade cancer, thereby making this patient an unlikely fit for Active Surveillance. Our Second Opinion board of experts reviewed this case, and a more comprehensive therapy was recommended.
Patient C was presented to our clinic with a low-grade cancer on the right side after a traditional biopsy. After 3D Staging Biopsy, we determined that he was an ideal candidate for Active Surveillance.
Both Patients A and C had low-grade cancer, however, treatments for each varied. Often times, the decision to watch or treat a small area of cancer may depend upon the patient’s personal preference.